1. Treat-to-target therapy does not prevent excessive progression of carotid intima media thickness during the first year of therapy in early rheumatoid arthritis.
- Author
-
Raczkiewicz A, Juszkiewicz A, Kisiel B, Bachta A, Kur-Zalewska J, Kłos K, Bujakowska O, Tłustochowicz M, and Tłustochowicz W
- Abstract
Introduction: The aim of the study was to investigate the presence of subclinical atherosclerosis and predictors of change in carotid intima-media measures in early rheumatoid arthritis patients (eRA) as compared to chronic RA patients and patients without arthritis., Material and Methods: Fifty-five consecutive eRA patients were assessed at the time of diagnosis and after 1 year of therapy. Fifty-five sex- and age-matched chronic RA patients and 29 patients without inflammatory disease were used as controls. Carotid artery intima-media thickness (CIMT) and carotid plaques were measured at baseline and after follow-up. In eRA patients ultrasound assessment of hand joints was performed before and after treatment. Carotid artery intima-media thickness was assessed again after 2 years in 44 eRA patients., Results: Carotid artery intima-media thickness progression after 1 year of therapy was higher in eRA patients compared to both control groups ( p = 0.017) and correlated with symptoms duration ( p = 0.017) and DMARD monotherapy ( p = 0.015). Ultrasound progression of hand joint erosions was associated with longer symptoms duration ( p = 0.006). After 2 years of observation CIMT progression was similar in all examined groups., Conclusions: We observed rapid CIMT progression during the first year of RA therapy. Longer symptoms duration and less aggressive therapy were associated with CIMT increase., Competing Interests: The authors declare no conflict of interest.
- Published
- 2016
- Full Text
- View/download PDF